|Elite Pharmaceuticals, Inc.|
165 Ludlow Avenue
United States - Map
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, principally engaged in the research, development, and licensing of proprietary controlled-release drug delivery systems and products. The company develops orally administered controlled-release products for various therapeutic areas, including pain, allergy, and infection. It owns, licenses, sells, and contract manufactures Phentermine tablets and capsules, Lodrane D Immediate Release capsules, Methadone tablets, Hydromorphone Hydrochloride tablets, Phendimetrazine tartrate tablets, and Naltrexone HCl tablets. The company also has a pipeline of other generic drug candidates under development; and is developing abuse resistant opioid products and once-daily opioid products. In addition, it is engaged in contract research and development on behalf of other pharmaceutical companies. The company has strategic alliance agreements with Epic Pharma, LLC and Epic Investments, LLC. Elite Pharmaceuticals, Inc. was founded in 1984 and is headquartered in Northvale, New Jersey.
|Mr. Nasrat Hakim ,
Chief Exec. Officer, Pres and Director
|Mr. Carter J. Ward B.S., CPA,
Chief Financial Officer, Chief Accounting Officer, Treasurer and Sec.
|Mr. Ashok G. Nigalaye Ph.D.,
Chief Scientific Officer, Director and Member of Compensation Committee
|Mr. Christopher C. Dick ,
|Mr. Doug Plassche ,
Exec. VP of Operations
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|